0B68 Berger, Adam - Thomas Jefferson University - Thomas Jefferson University
Adam Berger, MD, FACS

Adam Berger, MD, FACS

Contact Dr. Berger

1100 Walnut Street
MOB, Suite 500
Philadelphia, PA 19107

(215) 955-1622
(215) 923-8222 fax

Most Recent Peer-reviewed Publications

  1. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
  2. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells
  3. VPAC1 receptors for imaging breast cancer: A feasibility study
  4. Altered drainage patterns in patients with melanoma and previous axillary dissection
  5. Selectively starving cancer cells through dietary manipulation: Methods and clinical implications
  6. John Chalmers DaCosta (1863-1933): Restoration of the old operating table
  7. Major perioperative morbidity does not affect long-term survival in patients undergoing esophagectomy for cancer of the esophagus or gastroesophageal junction
  8. Serum Blood Urea Nitrogen and Serum Albumin on the First Postoperative Day Predict Pancreatic Fistula and Major Complications After Pancreaticoduodenectomy
  9. Laparoscopic approaches to gastric gastrointestinal stromal tumors: An institutional review of 57 cases
  10. Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial
  11. Hemorrhagic Hepatic Cyst: Report of a Case and Review of the Literature with Emphasis on Clinical Approach and Management
  12. Locally advanced pancreatic cancer
  13. Surgical Apgar Score Predicts Perioperative Morbidity in Patients Undergoing Pancreaticoduodenectomy at a High-Volume Center
  14. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma
  15. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: A secondary analysis of RTOG 9704
  16. BRCA1 and BRCA2 variants of uncertain significance. Part two: Medical management
  17. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?
  18. The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma
  19. Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy
  20. Is gastrectomy safe in the elderly? A single institution review
0